TickerFactsScreenerDevelopers

Dare Bioscience, Inc. (DARE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$21.00M2013: -$16.61M2014: -$19.06M2015: -$31.91M2016: -$372.3K2017: -$2.54M2018: -$10.30M2019: -$13.30M2020: -$25.20M2021: -$28.80M2022: -$18.10M2023: -$38.90M2024: $5.40M2025: -$9.90M-$9.90M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$9.90M-283.3%
2024$5.40M+113.9%
2023-$38.90M-114.9%
2022-$18.10M+37.2%
2021-$28.80M-14.3%
2020-$25.20M-89.5%
2019-$13.30M-29.1%
2018-$10.30M-305.5%
2017-$2.54M-582.3%
2016-$372.3K+98.8%
2015-$31.91M-67.4%
2014-$19.06M-14.7%
2013-$16.61M+20.9%
2012-$21.00M—